02/22/2026
Today for we have Freda C. Lewis-Hall. She earned her B.S. degree from Johns Hopkins University and her medical doctorate from Howard University in Washington, DC. She served as Pfizer, Inc.’s Chief Medical Officer and Executive Vice President until the end of 2018 and as Chief Patient Officer and Executive Vice President during 2019. Trained as a psychiatrist, Dr. Lewis-Hall has held an array of leadership roles across the healthcare and pharmaceutical sectors, as well as in academia, medical research, and direct service provision. In 2010, Dr. Lewis-Hall was appointed by the Obama Administration to the inaugural Board of Governors for the Patient-Centered Outcomes Research Institute (PCORI), and in 2012 she was appointed chair of the Cures Acceleration Network Review Board and a member of the National Center for Advancing Translational Sciences (NCATS) Advisory Council of the National Institutes of Health. She also serves on the Executive Committee of the Clinical Trials Transformation Initiative and on numerous other boards, including those of Harvard Medical School, The Institute of Medicine’s Forum on Drug Discovery, Development, and Translation, and Save the Children. Dr. Lewis-Hall has received several recognitions including being named as one of Savoy’s Top Influential Women in Corporate America in 2012, named “Woman of the Year” by Healthcare Businesswomen’s Associations in 2011, as well as being recognized in 2010 as one of the nation’s 75 Most Powerful Women in Business by Black Enterprise Magazine and among the 25 Most Influential African Americans in health care by Black Health Magazine.
